Patients' Frequently Asked QuestionsWho qualifies to participate in the NeuroRecovery Network?
At the present time, the program is open to individuals with an incomplete cervical or thoracic spinal cord injury who have some movement or muscle tone in their legs.
What steps does one have to take to receive treatment by the NRN?
Patients must have a referral from a physician to receive this therapy. All potential patients must be seen by the NRN physician and physical therapists at the NRN facility, to be screened for any complicating medical issues that would make this therapy inappropriate. Following this evaluation, if deemed appropriate for this therapy, a plan of treatment will be established.
How long will the course of therapy take?
The average person receives the therapy for three to four months, and will undergo around 60 sessions. Each patient is re-evaluated every 20 sessions. At that time, the NRN physicians and therapists will take any adjustments to the number of days per week and talk about the goals for the next 20 visits.
How much time will each Locomotor Training session take?
Each session generally lasts one and a half hours. When a patient enters the program, they start five days per week. As they progress through the phases of recovery, the number of days per week declines to four days/week and then three days/week.
What is the cost of receiving therapy through the NRN? Who will pay for it?
NRN sites are committed to working with every patient to secure reimbursement for participating in this program. It is expected that costs will be covered by your insurance company. Membership fees for Community Based NRN facilities are expected to be covered by the patient.
What should I bring to each session? Do I have to buy special equipment?
All patients need bring to a training session is loose-fitting clothes appropriate for physical activity. The equipment needed will be provided by the NRN.
What results can I expect? What long-term improvements to my health will this therapy provide?
A range of results and health improvements are reported in the scientific literature; others are beginning to emerge as we apply this therapy to human patients. What we know is that results will vary from patient to patient. No two NRN patients will respond in exactly the same way, nor is each patient likely to experience the entire range of possible changes and improvements.
This therapy may contribute to improved cardiovascular and pulmonary function and blood flow to the arms and legs. In some patients, it may boost the healing potential of the skin, help increase bone density, and improve bladder function. Functional results among NRN patients have ranged from improved trunk stability to recovery of standing and stepping ability.